TPI HLA-DR1 corresponds to a peptide segment derived from triosephosphate isomerase designed for HLA-DR1 binding research. The sequence contains residues contributing to MHC class II anchoring and stability. Researchers use it to examine antigen presentation, peptide-MHC conformation, and epitope mapping. Its defined structure supports detailed immunochemical analysis.
CAT No: ta-031
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More